Medicine in resource-poor settings: Time for a paradigm shift?

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 4, Issue 4, 2004, Pages 355-360

  Onen, Churchill Lukwiya ^a  

^a Centre for Chronic Diseases   (Botswana)

Author keywords

Developing countries; Global inequalities; Medicine; Paradigm shift; Physicians; Resource poor settings

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DEVELOPING COUNTRY; DIABETES MELLITUS; DISABILITY; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; HYPERTENSION; INDUSTRIALIZATION; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MALARIA; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICAL SCHOOL; OBESITY; PLASMODIUM FALCIPARUM; PREVENTIVE MEDICINE; PUBLIC HEALTH SERVICE; RESOURCE MANAGEMENT; RISK ASSESSMENT;

EID: 4243118740     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.4-4-355     Document Type: Conference Paper

References (11)

1. Global Forum for Health Research. The 10/90 report on health research 2003-2004. Geneva: Global Forum for Health Research, 2004.
2. UNDP 1999. Human development report. http://stone.undp.org/hdr/ reports/global/1999
3. World Health Organization. World health report 2002. www.who. int/whr/2002/en/
4. Royal College of Physicians, Royal College of Paediatrics & Child Health, Faculty of Public Health. Storing up problems: the medical case for a slimmer nation. Report of a working party. London: RCP, 2004.
5. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
6. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998;21:296-309.
7. Jönsson B, on behalf of the CODE-2 Advisory Board. Revealing the cost of type 2 diabetes in Europe. Diabetologia 2002;45:S5-S12.
8. Brown MJ, Haydock S. Pathoaetiology, epidemiology and diagnosis of hypertension. Drugs 2000;59 (Suppl 2):1-12.
9. Pepine CJ. Systemic hypertension and coronary artery disease. Am J Cardiol 1998;82:21H-24H.
10. Burt VL, Cutler JA, Higgins M, Horan MJ et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-69.
11. Grover SA, Abrahamowicz M, Joseph L, Brewer C et al. The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity. JAMA 1992;267:816-22.